Clinical Trials Sponsored by Medinova AG

Total 2389 results

Medinova AG

Completed

Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients (Gynoflor)

Atrophic Vaginitis

Belgium, Germany
Medinova AG

Terminated

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

Vaginal Diseases | Bacterial Vaginosis | Vaginal Infection

Slovakia, Czechia, Poland
Medinova AG

Completed

Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis

Bacterial Vaginosis

Switzerland, Czech Republic, Germany, Belgium, Slovakia
Medinova AG

Withdrawn

Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis

Vulvovaginal Candidiasis
Medinova AG

Completed

Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

Phlebitis | Thrombophlebitis

Thailand
Medinova AG
Mahidol University

Completed

Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Thailand
University Hospital Inselspital, Berne
Medinova AG

Completed

Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women

Postmenopause | Atrophy of Vagina

Switzerland
MediciNova

Recruiting

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Diabetes Mellitus, Type 2 | Hypertriglyceridemia | Non-Alcoholic Fatty Liver Disease

United States
MediciNova

Completed

Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis | IPF

United States
MediciNova

Completed

Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers

Healthy Volunteers

United States
MediciNova

Completed

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Asthma

United States
MediciNova

Terminated

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma

Asthma | Status Asthmaticus

United States
MediciNova

Completed

Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
MediciNova

Completed

Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

United States
MediciNova

Completed

Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Interstitial Cystitis

United States
MediciNova

Completed

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

Asthma

United States
MediciNova

Recruiting

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS (COMBAT-ALS)

Amyotrophic Lateral Sclerosis

United States, Canada
MediciNova

Active, not recruiting

Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma

Glioblastoma | GBM | Recurrent Glioblastoma | Newly Diagnosed Glioblastoma

United States
MediciNova

Active, not recruiting

Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS

Pneumonia, Viral

United States
MediciNova

Completed

Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD Subjects

Non-alcoholic Fatty Liver Disease | Hypercholesterolemia | Hypertriglyceridemia | Non-alcoholic Steatohepatitis

United States
MediciNova

Completed

Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers

Healthy Volunteers

United States
Medinol Ltd.

Recruiting

IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN)

Cardiovascular Diseases | Coronary Disease | Non-ST Elevated Myocardial Infarction | Coronary Stenosis

Israel, Brazil
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
Medinol Ltd.

Terminated

ChampioNIR® SFA Stent EFS Study

Peripheral Arterial Disease

Israel
Medinol Ltd.

Completed

BIONICS - Pharmacokinetics (PK) Trial (BIONICS)

Heart Disease

United States
Medinol Ltd.

Completed

BIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial

Myocardial Ischemia | Cardiovascular Diseases | Coronary Disease | Coronary Stenosis

Israel
Medinol Ltd.

Completed

BIONICS Israel Trial

Stenosis

Israel
Medinol Ltd.

Completed

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Ischemic Heart Disease

Israel, Sweden, Belgium, Germany
Medinol Ltd.

Not yet recruiting

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease (CHAMPIONSHIP)

Popliteal Artery Stenosis | Superficial Femoral Artery Stenosis
Medinol Ltd.

Completed

EluNIR Ridaforolimus Eluting Coronary Stent System in Patients at High Bleeding Risk (HBR)- EluNIR HBR Study

Coronary Stenosis

Israel
Medinol Ltd.

Completed

BIONICS 38 mm Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial

Coronary Stenosis

Israel
Medinol Ltd.

Not yet recruiting

IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

Coronary Artery Disease | Coronary Stenosis
Medinol Ltd.

Completed

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis (BIONICS)

Coronary Artery Stenosis

United States, Israel, Canada, Netherlands, Belgium, Italy, Poland, Spain
Medinol Ltd.

Completed

NIRTRAKS Post-Market Study (NIRTRAKS) (NIRTRAKS)

de Novo Stenotic Lesions in Native Coronary Arteries

United States
Medinol Ltd.

Completed

X-MAS Biliary Study With Covered Biliary Stent

Biliary Tract Cancer

Israel, Netherlands, Belgium
Medinol Ltd.

Completed

Angiography Study of BioNIR Drug Eluting Stent System (NIREUS) (NIREUS)

Coronary Artery Stenosis

Israel
Muğla Sıtkı Koçman University
Aydın Private Medinova Hospital

Unknown

The Functional Difficulties Questionnaire-shortened Version: Turkish Translation, Validity and Reliability Study.

Functional Status After CABG Surgery | Outcome Measure

Turkey
Valve Medical
Medinol Ltd.

Unknown

Dedicated Sheath Feasibility Study (BAV)

Aortic Stenosis

Israel
Bottneuro AG
Hemex AG

Active, not recruiting

Evaluate the Safety and Feasibility of tACS With the Miamind Neurostimulator in Healthy Participants (MindStim)

Healthy Participants | Healthy Population

Switzerland
Santersus AG
ISS AG

Not yet recruiting

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating cfDNA/NETs in Subjects With Sepsis (NUC-CAP)

Sepsis | Respiratory Failure

United Kingdom, Germany, Switzerland
SynDermix AG
ISS AG

Withdrawn

Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (SDX-3101)

Chronic Rhinosinusitis Without Nasal Polyps

Germany, Austria, Switzerland
Tetec AG
Aesculap AG

Completed

Observational Study With NOVOCART® Inject in the Reconstruction of the Hip Joint With Full Thickness Cartilage Defects (HIP-ACTION)

Cartilage Disease

Germany
Tetec AG
Aesculap AG

Completed

Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects (NISANIK)

Cartilage Diseases

Germany
Hospital Medina del Campo

Recruiting

Are Double-ring Wound-edge Protectors Effective for Preventing Superficial Surgical Site Infection After Open Appendectomy? (sSSI-2RWEPs)

Surgical Site Infection | Acute Appendicitis

Spain
Hospital Medina del Campo

Completed

Serratus-intercostal Plane Block Versus Quadratus Lumborum Block in Nephrectomy: Randomized Study

Kidney Injury

Spain
iOMEDICO AG
Roche Pharma AG

Active, not recruiting

Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion (REALTRK)

NTRK Family Gene Mutation

Switzerland, Germany
iOMEDICO AG
Roche Pharma AG

Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy (CHAPLIN)

Extensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC

Germany
Spiden AG
DCB Research AG

Completed

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
MediciNova
Wake Forest University Health Sciences

Completed

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS) (IBU-ALS-1201)

Amyotrophic Lateral Sclerosis

United States
Hospital Medina del Campo

Completed

Serratus Intercostal Plane Block,New Analgesia in Supraumbilical Surgery (SIPB)

Postoperative Pain | Analgesia | Local Anaesthetic | Abdominal Injury

Spain

3

Subscribe